White matter hyperintensities predict amyloid increase in Alzheimer's disease
暂无分享,去创建一个
Florian Auer | Timo Grimmer | Christian Sorg | Gjermund Henriksen | Alexander Drzezga | Robert Perneczky | Panagiotis Alexopoulos | Hans Förstl | Behrooz H. Yousefi | C. Sorg | A. Drzezga | A. Kurz | R. Perneczky | F. Auer | P. Alexopoulos | T. Grimmer | M. Faust | H. Förstl | G. Henriksen | B. Yousefi | Alexander Kurz | Maximilian Faust
[1] M. Folstein,et al. Clinical diagnosis of Alzheimer's disease , 1984, Neurology.
[2] Yaakov Stern,et al. Measuring cerebral atrophy and white matter hyperintensity burden to predict the rate of cognitive decline in Alzheimer disease. , 2008, Archives of neurology.
[3] C. Patlak,et al. Drainage of interstitial fluid from different regions of rat brain. , 1984, The American journal of physiology.
[4] A. Hofman,et al. Cerebral white matter lesions and the risk of dementia. , 2004, Archives of neurology.
[5] R. Weller. Pathology of Cerebrospinal Fluid and Interstitial Fluid of the CNS: Significance for Alzheimer Disease, Prion Disorders and Multiple Sclerosis , 1998, Journal of neuropathology and experimental neurology.
[6] H. Braak,et al. Phases of Aβ-deposition in the human brain and its relevance for the development of AD , 2002, Neurology.
[7] G. Waldemar,et al. The apolipoprotein E ɛ4‐allele and antihypertensive treatment are associated with increased risk of cerebral MRI white matter hyperintensities , 2007 .
[8] U Seligsohn,et al. Improved method for genotyping apolipoprotein E polymorphisms by a PCR-based assay simultaneously utilizing two distinct restriction enzymes. , 1997, Clinical chemistry.
[9] M Schwaiger,et al. Effect of APOE genotype on amyloid plaque load and gray matter volume in Alzheimer disease , 2009, Neurology.
[10] D. Thal. The Precapillary Segment of the Blood-Brain Barrier and Its Relation to Perivascular Drainage in Alzheimer's Disease and Small Vessel Disease. , 2009, TheScientificWorldJournal.
[11] J. Hoffman,et al. FDG PET imaging in patients with pathologically verified dementia. , 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[12] S. Folstein,et al. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.
[13] A. Drzezga,et al. Beta Amyloid in Alzheimer's Disease: Increased Deposition in Brain Is Reflected in Reduced Concentration in Cerebrospinal Fluid , 2009, Biological Psychiatry.
[14] P. Scheltens,et al. A semiquantative rating scale for the assessment of signal hyperintensities on magnetic resonance imaging , 1993, Journal of the Neurological Sciences.
[15] J. Morris,et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assesment of Alzheimer's disease , 1989, Neurology.
[16] W. Klunk,et al. Progression of Cerebral Amyloid Load Is Associated with the Apolipoprotein E ε4 Genotype in Alzheimer's Disease , 2010, Biological Psychiatry.
[17] Jan Cees de Groot,et al. Interaction Between Hypertension, apoE, and Cerebral White Matter Lesions , 2004, Stroke.
[18] Lisa A. Weissfeld,et al. Evaluation of voxel-based methods for the statistical analysis of PIB PET amyloid imaging studies in Alzheimer's disease , 2006, NeuroImage.
[19] Karl J. Friston,et al. Statistical parametric maps in functional imaging: A general linear approach , 1994 .
[20] W. W. Zhang,et al. Could changes in arterioles impede the perivascular drainage of interstitial fluid from the cerebral white matter in leukoaraiosis? , 2010, Neuropathology and applied neurobiology.
[21] Timo Grimmer,et al. Clinical severity of Alzheimer's disease is associated with PIB uptake in PET , 2009, Neurobiology of Aging.
[22] L. Pantoni. Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges , 2010, The Lancet Neurology.
[23] David M Holtzman,et al. Human apoE Isoforms Differentially Regulate Brain Amyloid-β Peptide Clearance , 2011, Science Translational Medicine.
[24] J. Morris,et al. Decreased Clearance of CNS β-Amyloid in Alzheimer’s Disease , 2010, Science.
[25] E. Zhang,et al. Directional and compartmentalised drainage of interstitial fluid and cerebrospinal fluid from the rat brain , 2004, Acta Neuropathologica.
[26] Satoshi Minoshima,et al. Imaging Alzheimer's disease: clinical applications. , 2003, Neuroimaging clinics of North America.
[27] J. Hardy,et al. The Amyloid Hypothesis of Alzheimer ’ s Disease : Progress and Problems on the Road to Therapeutics , 2009 .
[28] C. DeCarli,et al. What does fluorodeoxyglucose PET imaging add to a clinical diagnosis of dementia? , 2007, Neurology.
[29] H. Braak,et al. Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.
[30] R O Weller,et al. Solutes, but not cells, drain from the brain parenchyma along basement membranes of capillaries and arteries: significance for cerebral amyloid angiopathy and neuroimmunology , 2008, Neuropathology and applied neurobiology.
[31] Marie-Claude Potier,et al. Classification and basic pathology of Alzheimer disease , 2009, Acta Neuropathologica.
[32] C. Sudlow,et al. Genetic Determinants of White Matter Hyperintensities on Brain Scans: A Systematic Assessment of 19 Candidate Gene Polymorphisms in 46 Studies in 19 000 Subjects , 2009, Stroke.
[33] Keith A. Johnson,et al. Imaging of amyloid burden and distribution in cerebral amyloid angiopathy , 2007, Annals of neurology.